December 3, 2020

WATCH: SRP-9001 Gene Therapy Path Forward (Webinar Recording)

Parent Project Muscular Dystrophy and Sarepta Therapeutics hosted a webinar on November 24, 2020 for a discussion about the SRP-9001 gene therapy development program. If you missed the live event, the recording can be found…

Learn More

November 25, 2020

I’m thankful for what we have in each other.

This year. This Thanksgiving. How did we get here? This year has tested our will, our resilience, and our courage. I still have a turkey in the oven and dessert in the fridge, but my…

Learn More

November 25, 2020

Antisense Therapeutics: Introduction to the Duchenne Community

PPMD is thrilled to welcome Antisense Therapeutics to the Duchenne community. Antisense is developing a new potential therapy, ATL1102, using an antisense oligonucleotide (ASO) inhibitor aimed at treating muscle inflammation and associated muscle wasting. Although…

Learn More

November 22, 2020

Lilly and Precision BioSciences Announce Genome Editing Research Collaboration and License Agreement

PPMD is excited to welcome Lilly back to the Duchenne space! With Lilly’s experience in Duchenne, we are thrilled to see their return to the field and look forward to learning more as this early…

Learn More

November 21, 2020

NEW – Fall 2020 Survey: Impact of the COVID-19 Pandemic on Duchenne

PPMD has launched our second COVID-19 Pandemic Impact Survey related to your experiences during the pandemic for accessing care, trials, and approved therapies. Thank you to everyone who completed our first survey earlier in the spring….

Learn More

November 20, 2020

Attend PPMD’s Community Concert: Harmony Together

Join us on Sunday, November 22 at 7 PM EST for an incredible evening of music on the PPMD Facebook Page! PPMD’s Community Concert: Harmony Together will feature members of the Duchenne community sharing their…

Learn More

November 19, 2020

15th Annual Sam’s Night Raises Over $500,000 in the Fight to End Duchenne

Another historic year for Sam’s Night! Last week, the Killian Family and friends joined “together” to celebrate PPMD’s longest running signature DIY event. With $506,294 raised, 2020 marked the 15th Anniversary, the first virtual edition,…

Learn More

November 18, 2020

Shop Throughout the Holiday Season and Support PPMD at the Same Time

Shop for gifts this holiday season with AmazonSmile or while rounding up your spare change using the Cheerful app and generate donations for PPMD. Round Up your Spare Change Round up on your purchases to…

Learn More

November 17, 2020

ReveraGen Receives $3.3 Million NIH Grant for NDA Preparations for Vamorolone in Duchenne

The National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) has awarded a $3.3 million grant to ReveraGen Inc. to support the advancement of vamorolone towards FDA submission and…

Learn More

November 16, 2020

Duchenne UK, MDA & PPMD Award $686,500 Grant To Develop Easier Way To Measure if New Treatments Are Working

In an unprecedented collaboration designed to speed research advances, Duchenne UK, the Muscular Dystrophy Association (MDA), and Parent Project Muscular Dystrophy (PPMD) have announced a joint grant of $686,500 to Dr. William Evans (principal investigator)…

Learn More